ÂÜÀòÂÒÂ×

Libby Morris is an accomplished professional with extensive experience in oncology and hematology, currently serving as an Oncology Strategy Leader and Program Team Lead at Amgen since February 2024. Previous roles include Program Strategy Leader at Gilead Sciences, overseeing a complex oncology program, and multiple leadership positions at Genentech, where responsibilities encompassed commercial development and early medicines development for oncology treatment strategies. Libby also held significant marketing roles at Roche, Bristol Myers Squibb, and Hoffmann-La Roche, where expertise was demonstrated in launching and managing brands in oncology and HIV, as well as driving strategic initiatives and cross-functional collaboration in global markets.